152 related articles for article (PubMed ID: 6273989)
1. [Post-tuberculosis syndromes appearing in cases undergoing initial chemotherapy].
Didilescu C
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1981; 30(3):173-6. PubMed ID: 6273989
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of non-tuberculous pulmonary mycobacteriosis].
Sakatani M; Nakajima Y
Kekkaku; 2006 Jan; 81(1):35-50. PubMed ID: 16479999
[TBL] [Abstract][Full Text] [Related]
3. [Post-tuberculosis syndromes in a pneumology unit].
Unteanu G; Pârvulescu P
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1977; 26(4):211-6. PubMed ID: 204973
[TBL] [Abstract][Full Text] [Related]
4. Tuberculous subcutaneous abscesses developing during chemotherapy for pulmonary tuberculosis.
Chen CH; Tsai JJ; Shih JF; Perng RP
Scand J Infect Dis; 1993; 25(1):149-52. PubMed ID: 8460341
[TBL] [Abstract][Full Text] [Related]
5. [Non-specific late bronchopulmonary sequelae of grave tuberculosis in infants].
Buşilă-Corăbianu E; Teodorescu L
Pediatria (Bucur); 1970; 19(1):65-71. PubMed ID: 5310219
[No Abstract] [Full Text] [Related]
6. [Individual approaches to complex treatment of disseminated tuberculous processes in adolescents].
Gergert VIa; Rusakova LI
Probl Tuberk Bolezn Legk; 2006; (8):33-7. PubMed ID: 17002056
[TBL] [Abstract][Full Text] [Related]
7. [Tuberculosis and cancer: primary lung cancer cases after treatment with anti-tuberculous drugs].
Sato H; Kayaba K; Oizumi K; Motomiya M
Kekkaku; 1989 Jul; 64(7):465-9. PubMed ID: 2585947
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy of chemotherapy of pulmonary tuberculosis drug-resistant m.tuberculosis].
Khomenko AG; Chukanov VI; Korneev AA
Probl Tuberk; 1996; (6):42-4. PubMed ID: 9019768
[TBL] [Abstract][Full Text] [Related]
9. [Case of pubic tuberculous osteomyelitis and pericarditis during anti-tuberculosis chemotherapy].
Ohkouchi M; Inase N; Yasui M; Miura H
Kekkaku; 2004 Sep; 79(9):531-5. PubMed ID: 15552940
[TBL] [Abstract][Full Text] [Related]
10. [Estimation of the possibilities of using unified chemotherapy regimens in new cases of pulmonary tuberculosis in old-age children and adolescents].
Gubkina MF; Ershova NG
Probl Tuberk Bolezn Legk; 2009; (1):33-6. PubMed ID: 19256010
[TBL] [Abstract][Full Text] [Related]
11. [Cured chronic pulmonary tuberculosis].
Pşegalinschi N; Moscalu G
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1976; 25(3):179-82. PubMed ID: 188102
[TBL] [Abstract][Full Text] [Related]
12. [Results of use of surfactant in complex therapy of patients with destructive pulmonary tuberculosis].
Lovacheva OV; Erokhin VV; Chernichenko NV; Evgushchenko GV; Lepekha LN; Rozenberg OA
Probl Tuberk Bolezn Legk; 2006; (10):12-7. PubMed ID: 17139825
[TBL] [Abstract][Full Text] [Related]
13. Tuberculous meningitis developing during course of chemotherapy for tuberculosis including isoniazid--report of two cases.
Mital VN; Misra M; Gupta OP
J Assoc Physicians India; 1980 Sep; 28(9):311-3. PubMed ID: 7462137
[No Abstract] [Full Text] [Related]
14. [Bronchial sequelae to secondary tuberculosis. II. Bronchial manifestations of the post-tuberculous syndrome].
Stinghe R; Mangiulea V; Teodorescu L; Ivanov G
Ftiziologia; 1972; 21(4):387-99. PubMed ID: 4644564
[No Abstract] [Full Text] [Related]
15. [Economic and social implications of post-tuberculosis syndromes].
Didilescu C
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1982; 31(1):57-62. PubMed ID: 6289418
[TBL] [Abstract][Full Text] [Related]
16. [Investigation on the treatment of infection due to Mycobacterium Kansasii].
Nakazono T; Sugie T; Ogata H; Mizutani S; Sugita H; Kino T; Wada M
Kekkaku; 1994 Oct; 69(10):587-92. PubMed ID: 7799569
[TBL] [Abstract][Full Text] [Related]
17. [Considerations on the results of initial chemotherapy in pulmonary tuberculosis].
Străuţiu R; Tătaru I; Brandabur V; Baldovin M; Beleuţă G; Enache T; Gheorghiu S; Mihalciuc M; Panaite I
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1982; 31(2):177-84. PubMed ID: 6294810
[TBL] [Abstract][Full Text] [Related]
18. [Use of lymphotropic therapy in the multimodality treatment of patients with pulmonary tuberculosis and comorbidity].
Ubaĭdullaev AM; Belotserkovets VG
Probl Tuberk Bolezn Legk; 2004; (12):50-2. PubMed ID: 15719669
[TBL] [Abstract][Full Text] [Related]
19. [Failures of standardized treatments in pulmonary tuberculosis. Possibilities of prevention and therapeutic recovery].
Sava N; Stanca-Circioiu M; Gartner A; Anastasatu C
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1981; 30(3):165-72. PubMed ID: 6273988
[TBL] [Abstract][Full Text] [Related]
20. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
